FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 118 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 280 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 280 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 280 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 280 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 280 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -42.9% | 280 | -37.8% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 450 | +66.7% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 270 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -45.5% | 270 | 0.0% | 0.00% | – |
| Q3 2017 | $11,000 | +37.5% | 270 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | -20.0% | 270 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | -60.0% | 270 | -46.0% | 0.00% | – |
| Q4 2016 | $25,000 | -3.8% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $26,000 | +23.8% | 500 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,781,346 | $25,867,000 | 3.38% |
| GREAT POINT PARTNERS LLC | 2,398,409 | $22,305,000 | 2.82% |
| Sofinnova Investments, Inc. | 315,344 | $2,933,000 | 0.36% |
| EcoR1 Capital, LLC | 326,775 | $3,039,000 | 0.30% |
| Rock Springs Capital Management LP | 505,000 | $4,697,000 | 0.22% |
| Hilltop Holdings Inc. | 36,146 | $336,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 285,237 | $2,653,000 | 0.07% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 191,237 | $1,779,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,132 | $113,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,427 | $292,000 | 0.05% |